Improve Cardiovascular Treatment Outcomes by Diagnosing and Treating Your Patients’ Sleep Apnea in 1-2 Weeks

Interested in learning more?

Leave your details, and an Itamar Medical associate will contact you to explain how you can offer your cardiology patients a complete “from home” sleep apnea diagnosis and treatment program – today.

Fact #1: Undiagnosed sleep apnea is a major comorbidity of CVD

It is also a significant risk factor for stroke, coronary artery disease, congestive heart failure and AFib1. Sleep apnea puts an enormous strain on the heart, and remodels the cardiac substrate through stretching, oxidative stress and frequent sympathetic surges2.

Fact #2: Sleep Apnea Increases the Risk of AFib Recurrence

Sleep disordered breathing creates abnormal atrial substrate which can initiate AFib triggers.3 Left untreated, sleep apnea in AFib patients predicts recurrence of AFib, and leads to poor intervention outcomes.4

Fact #3: Improving Treatment Outcomes Couldn’t Be Easier.

Here’s the really good news. Even with patients at home, WatchPAT® Turnkey offers a complete care pathway for sleep apnea diagnosis and treatment to improve your treatment outcomes. It’s safe, simple and 100% hassle-free.

Treat Sleep Apnea With WatchPAT® TurnKey

No Cost to the Account - No Need to Deal with Billing - No Additional Work

Sleep apnea puts 1 in 2 cardiac patients at greater risk…

Left untreated, sleep apnea may increase risk for stroke3, death from sudden cardiac arrest4, cardiovascular disease progression, and AFib recurrence after ablation.

Improving CVD treatment outcomes is as easy as the click of a button

The WatchPAT® Turnkey program is a comprehensive remote care pathway for sleep apnea diagnosis and treatment, using the simple, accurate and reliable, WatchPAT® Home Sleep Apnea Test.

Start improving cardiovascular treatment outcomes in 1-2 weeks!

Designed as a quick turnaround and turnkey solution, diagnosis and treatment can be completed in as little as 1-2 weeks. Post referral, the Itamar Medical team takes care of all administration, placing no extra cost or burden on the physician.

  1. Obstructive Sleep Apnea: Preoperative Assessment, Seet & Chung, Anesthesiology Clin (2010) 199-215.
  2. Anter E. Circulation: Arrhythmia and Electrophysiology. 2017, Atrial Substrate and Triggers of Paroxysmal Atrial Fibrillation in Patients with Obstructive Sleep Apnea
  3. Obstructive Sleep Apnea–Hypopnea and Incident Stroke-The Sleep Heart Health Study, Redline et al, American Journal of Respiratory and Critical Care Medicine Vol 182 2010;
  4. Obstructive Sleep Apnea and the Risk of Sudden Cardiac Death Gami et al, J Am Coll Cardiol 2013:

MedAxiom, an American College of Cardiology Company, is the cardiovascular community’s premier source for organizational performance solutions.